Biotech

All Articles

Arrowhead fires off phase 3 information in unusual metabolic condition in front of market encounter Ionis

.Arrowhead Pharmaceuticals has actually shown its hand in advance of a potential showdown along with...

Pfizer, Valneva present lyme condition shot reliable for second enhancer

.Pfizer and Valneva may have concerning two even more years to stand by before they make the very fi...

Fierce Biotech Managing Editor Ayla Ellison Speaks Patronize Michelle Benz on the Future of Biotech.

.Permit's study a chat with Ayla Ellison, Ferocious Biotech Managing Editor as well as Michelle Benz...

New records show how Bayer's asundexian stopped working to prevent movements

.Bayer suspended the stage 3 trial for its factor XIa prevention asundexian late last year after the...

Sanofi's tolebrutinib falls short 2 of 3 late-stage MS trials

.Sanofi is still set on taking its own several sclerosis (MS) med tolebrutinib to the FDA, execs hav...

Galapagos' stockpile as fund reveals intent to shape its own progression

.Galapagos is actually coming under extra stress coming from capitalists. Having actually created a ...

Cell- focused Sana gathers very first CSO-- Chutes &amp Ladders

.Accept to today's Chutes &amp Ladders, our roundup of considerable leadership hirings, firings and ...

Allist settles Jacobio $21M, landing job in Chinese KRAS nationality

.Shanghai Allist Pharmaceuticals has bought itself a starring role in China's KRAS market, spending ...

ReNeuron leaving AIM swap after overlooking fundraising goal

.ReNeuron has signed up with the long checklist of biotechs to leave London's AIM securities market....

MBX files for IPO to take opposition to Ascendis into period 3

.MBX Biosciences has contributed to the latest outbreak of IPO filings. The biotech, which filed its...